Floatz logo

RAMIFENTANYL

General Anesthesia

University Hospital, Clermont-FerrandSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

11 Active assets in the General Anesthesia cohort.

Asset / SponsorPhaseRating
Remimazolam
Seoul National University Bundang Hospital
Phase 4BB
ISOFLURANE
Duke University
Phase 1CC
PROPOFOL
University Hospital, Clermont-Ferrand
Phase 1CC
Oxygen
The Cleveland Clinic
N/AD
NEPENTHE
Medical University of Lodz
N/AD

View all 14 →

Same molecule, other indications

RAMIFENTANYL is also rated in:

morbid obesityDormant
BBB
Indicative ·
73 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative ·
73 / 100
View asset →
Anesthesia, GeneralDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →